Suzanne Bujara

Most Recent Articles by Suzanne Bujara

Schizophrenia Add-Ons: Beware the Flawed Meta-Analyses Touting Improvements

Schizophrenia Add-Ons: Beware the Flawed Meta-Analyses Touting Improvements

By

Clinicians should be discerning when evaluating meta-analyses of schizophrenia add-on therapies such as statins and antidepressants.

Long-Term Lithium Use: More Evidence Needed to Associate With Cancer Risk

Long-Term Lithium Use: More Evidence Needed to Associate With Cancer Risk

By

The European Medicine Agency has reported that there may be an association between long-term lithium use and reports of both renal tumors and thyroid cancer.

Schizophrenia Therapy Adherence Tied to Patients' Beliefs

Schizophrenia Therapy Adherence Tied to Patients' Beliefs

By

Given the substantial burden of nonadherence to therapy in patients with schizophrenia, new interventions for compliance are critical.

Predicting Poststroke Depression: Biomarkers and Beyond

Predicting Poststroke Depression: Biomarkers and Beyond

By

As depression is one of the most common psychiatric disorders following acute stroke and can be predictive of poor outcomes, identifying biomarkers to recognize the disorder are imperative for improving the clinical course.

Managing Comorbid Opioid and Alcohol Use Disorder

Managing Comorbid Opioid and Alcohol Use Disorder

By

When alcohol and opioid addiction occur together, managing them concomitantly becomes challenging. Whereas some patients may not need medication for alcohol addiction, opioid abuse does require pharmacotherapy.

More Articles by Suzanne Bujara

Sign Up for Free e-newsletters